8-KEarnings & ResultsExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Financial Results (Feb 6, 2024)

Filed February 6, 2024For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) has filed an 8-K report on February 6, 2024, to announce its fourth quarter and full fiscal year 2023 financial results. The core of this filing is the accompanying press release (Exhibit 99), which details the company's performance. Investors should note that the information furnished in this report, specifically regarding the financial results, is not considered "filed" for the purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities as formally filed information. However, it serves as the primary source for understanding GEHC's recent financial standing and operational outcomes for the periods ending December 31, 2023. While the 8-K itself is brief, it directs investors to the press release for comprehensive financial data, including revenue, earnings, and potentially guidance for future periods. Investors will need to review Exhibit 99 to gain a full understanding of GEHC's profitability, growth drivers, and any significant financial events or strategic updates disclosed for the fourth quarter and the entirety of fiscal year 2023. This filing is a standard mechanism for publicly traded companies to disseminate timely financial information to the market.

Key Highlights

  • 1GE HealthCare Technologies Inc. (GEHC) announced its Q4 and full-year 2023 financial results on February 6, 2024, via an 8-K filing.
  • 2The financial results are detailed in a press release furnished as Exhibit 99 to the 8-K.
  • 3Information provided in the 8-K, including Exhibit 99, is furnished and not deemed 'filed' under Section 18 of the Exchange Act.
  • 4This filing serves as the official channel for investors to access GEHC's latest financial performance data.
  • 5Investors should refer to Exhibit 99 for specific details on revenue, earnings, and other key financial metrics for Q4 and FY2023.
  • 6The 8-K also includes the Inline XBRL cover page (Exhibit 104) for regulatory compliance.

Frequently Asked Questions

The detailed financial results are provided in the press release furnished as Exhibit 99 to the 8-K filing dated February 6, 2024.

Information that is 'furnished' under Item 2.02 is typically used for informational purposes and is not subject to the same legal liabilities under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'. However, it is still crucial for investors to review for performance insights.

The 8-K filing itself does not typically contain guidance. Guidance and future outlook are usually discussed within the accompanying press release (Exhibit 99) or in subsequent investor calls. Investors should carefully review Exhibit 99 for any forward-looking statements or guidance provided by GE HealthCare.

This specific 8-K filing, as described, primarily focuses on the announcement of financial results. Any material business updates or significant events would typically be detailed within the press release (Exhibit 99) or reported under other specific 8-K item numbers if they were distinct events. Investors should review Exhibit 99 thoroughly.